Improvement of endothelial dysfunction by angiotensin II blockade accompanied by induction of vascular hepatocyte growth factor system in diabetic spontaneously hypertensive rats

Heart and Vessels

Volumn 18, Issue 1, 2003, Pages 18-25

  Matsumoto, Keiko ^a   Morishita, Ryuichi ^a   Tomita, Naruya ^a   Moriguchi, Atsushi ^a   Komai, Norio ^a   Aoki, Motokuni ^a   Matsumoto, Kunio ^a   Nakamura, Toshikazu ^a   Higaki, Jitsuo ^a   Ogihara, Toshio ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiotensin II receptor antagonist; Angiotensin converting enzyme inhibitor; Diabetes; Endothelial cell; Hypertension

Indexed keywords

ACETYLCHOLINE; ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GROWTH FACTOR; QUINAPRIL; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CELL DIVISION; CELL FUNCTION; CELL GROWTH; CONTROLLED STUDY; DIABETIC HYPERTENSION; DIAGNOSTIC KIT; DRUG EFFECT; ENDOTHELIUM LESION; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN SYNTHESIS; RAT; RAT STRAIN; SPONTANEOUSLY HYPERTENSIVE RAT; STRAIN DIFFERENCE; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VASODILATATION;

ACETYLCHOLINE; ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIUM, VASCULAR; HEPATOCYTE GROWTH FACTOR; IMMUNOHISTOCHEMISTRY; ISOQUINOLINES; MALE; MUSCLE, SMOOTH; PROTO-ONCOGENE PROTEINS C-MET; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTORS, ANGIOTENSIN; TETRAHYDROISOQUINOLINES;

EID: 0346153011     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003800300003     Document Type: Article

References (48)

1. Cohn JM, Finkelstein SM (1992) Abnormalities of vascular compliance in hypertension, aging and heart failure. J Hypertens 10:561-564
2. Lockette W, Otsuka Y, Carretero OA (1986) The loss of endothelium-dependent vascular relaxation in hypertension. Hypertension 8:II61-II66
3. Diedrich D, Yang Z, Buhler FR, Luscher TF (1988) Impaired endothelium-dependent relaxation in hypertensive resistance arteries involves cyclooxygenase pathway. Am J Physiol 258:H445-H451
4. Panza JA, Quyyumi AA, Brush JE, Epstein SE (1990) Abnormal endothelium-dependent relaxation in patients with essential hypertension. N Engl J Med 323:22-27
5. Dzau VJ (1993) The role of mechanical and humoral factors in growth regulation of vascular smooth muscle cells and cardiac myocytes. Curr Opin Nephrol Hypertens 2:27-32
6. Dzau VJ, Gibbons GH (1991) Endothelium and growth factors in vascular remodeling of hypertension. Hypertension 18 (suppl III):III115-III121
7. Thuillez C, Mulder P, Elfertak L, Blaysat G, Compagnon P, Henry JP, Richard V, Scalbert E, Desche P (1995) Prevention of endothelial dysfunction in small and large arteries in a model of chronic heart failure. Effect of angiotensin converting enzyme inhibition. Am J Hypertens 8:7S-12S
8. Piana RN, Wang SY, Friedman M, Sellke FW (1996) Angiotensin converting enzyme inhibition preserves endothelium-dependent coronary microvascular responses during short-term ischemia-reperfusion. Circulation 93:544-551
9. Iwatsubo H, Nagano M, Sakai T, Kumamoto K, Morita R, Higaki J, Ogihara T, Hata T (1997) Converting enzyme inhibitor improves forearm reactive hyperemia in essential hypertension. Hypertension 29:286-290
10. Creager MA, Roddy MA (1994) Effect of captopril and enalapril on endothelial function in hypertensive patients. Hypertension 24:499-505
11. Takeda K, Fujita H, Nakamura K, Uchida A, Tanaka M, Itoh H, Nakata T, Sasaki S, Nakagawa M (1994) Effect of an angiotensin II receptor antagonist, TCV-116, on cardiac hypertrophy and coronary circulation in spontaneously hypertensive rats. Blood Press 5:94-98
12. Oddie CJ, Dilley RJ, Kanekkakis P, Bobik A (1993) Chronic angiotensin II type 1 receptor antagonism in genetic hypertension: effects on vascular structure and reactivity. J Hypertens 11:717-724
13. Nakano N, Moriguchi A, Morishita R, Kida I, Tomita N, Matsumoto K, Nakamura T, Higaki J, Ogihara T (1997) Role of angiotensin II in the regulation of a novel vascular modulator, hepatocyte growth factor, in experimental hypertensive rats. Hypertension 30:1448-1454
14. Nakano N, Morishita R, Moriguchi A, Nakamura Y, Hayashi S, Aoki M, Kida I, Matsumoto K, Nakamura T, Higaki J, Ogihara T (1998) Negative regulation of local hepatocyte growth factor (HGF) expression by angiotensin II and transforming growth factor-β in blood vessels: potential role of HGF in cardiovascular disease. Hypertension 32:444-451
15. Matsumoto K, Morishita R, Moriguchi A, Tomita N, Aoki M, Sakonjo H, Matsumoto K, Nakamura T, Higaki J, Ogihara T (2001) Inhibition of neointima by ACE inhibitor in porcine coronary artery balloon injury model. Hypertension 37:270-274
16. Kannel WB, McGee DL (1979) Diabetes and glucose tolerance as risk factors for cardiovascular disease. Diabetes Care 241:2035-2038
17. Hsueh WA, Anderson PW (1992) Hypertension, the endothelial cell, and the vascular complications of diabetes mellitus [clinical conference]. Hypertension 20:253-263
18. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986
19. Tesfamariam B, Brown ML, Cohen RA (1991) Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C. J Clin Invest 87:1643-1648
20. Pieper GM, Meier DA, Hager SR (1995) Endothelial dysfunction in a model of hyperglycemia and hyperinsulinemia. Am J Physiol 269:H845-H850
21. McVeigh GE (1994) Hyperinsulinemia, insulin resistance, and endothelial dysfunction. Curr Opin Nephrol Hypertens 3:365-369
22. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD (1996) Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 97:2601-261O
23. Morishita R, Nakaumura S, Nakamura Y, Aoki M, Moriguchi A, Kida I, Yo Y, Matsumoto K, Nakamura T, Higaki J, Ogihara T (1997) Potential role of endothelium-specific growth factor, hepatocyte growth factor, on endothelial damage in diabetes mellitus. Diabetes 46:138-142
24. Morishita R, Higaki J, Hayashi S, Yo Y, Aoki M, Nakaumura S, Moriguchi A, Matsushita H, Matsumoto K, Nakamura T, Ogihara T (1997) Role of hepatocyte growth factor in endothelial regulation: prevention of high D-glucose-induced endothelial cell death by prostaglandins and phosphodiesterase type 3 inhibitor. Diabetologia 40:1053-1061
25. Nakamura S, Morishita R, Moriguchi A, Yo Y, Nakamura Y, Hayashi S, Matsumoto K, Nakamura T, Higaki J, Ogihara T (1998) Hepatocyte growth factor as a potential index of complication in diabetes mellitus. J Hypertens 16:2019-2026
26. Hayashi K, Nakamura S, Morishita R, Moriguchi A, Aoki M, Matsumoto K, Nakamura T, Kaneda Y, Sakai N, Ogihara T (2000) In vivo transfer of human hepatocyte growth factor gene accelerates re-endothelialization and inhibits neointimal formation after balloon injury in rat model. Gene Ther 7:1664-1671
27. Tsuda H, Iwase T, Matsumoto K, Ito M, Nishida Y, Oyama F, Titani K, Ushijima T, Nagao M, Hirono I (1992) Immunohistochemical localization of hepatocyte growth factor protein in pancreas islet A-cells of man and rats. Jpn J Cancer Res 83:1262-1266
28. Nakamura T, Mizuno S, Matsumoto K, Sawa Y, Matsuda H, Nakamura T (2000) Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF. J Clin Invest 106:1511-1519
29. Yamada A, Matsumoto K, Iwanari H, Ichida T, Asakura H, Komoriya Y, Nishiyama E, Nakamura T (1995) Rapid and sensitive enzyme-linked immunosorbent assay for measurement of HGF in rat and human tissues. Biomed Res 16:105-114
30. Morishita R, Gibbons GH, Ellison KE, Lee W, Zhang L, Yu H, Kaneda Y, Ogihara T, Dzau VJ (1994) Evidence for direct local effect of angiotensin in vascular hypertrophy: in vivo gene transfer of angiotensin converting enzyme. J Clin Invest 94:978-984
31. Nakamura Y, Morishita R, Higaki J, Kida I, Aoki M, Moriguchi A, Yamada K, Hayashi S, Yo Y, Nakano N, Matsumoto K, Nakamura T, Ogihara T (1995) Expression of local hepatocyte growth factor system in vascular tissues. Biochem Biophys Res Commun 215:483-488
32. Nakamura T, Hagiya M, Nishizawa T, Seki T, Shimonishi M, Sugimura A, Tashiro K, Shimizu S (1989) Molecular cloning and expression of human hepatocyte growth factor. Nature 342:440-443
33. Nakagami H, Morishita R, Yamamoto K, Taniyama Y, Aoki M, Kim S, Matsumoto K, Nakamura T, Higaki J, Ogihara T (2000) Anti-apoptotic action of hepatocyte growth factor (HGF) through mitogen-activated protein kinase on human aortic endothelial cells. J Hypertens 18:1411-1420
34. Yamamoto K, Morishita R, Hayashi S, Matsushita H, Nakagami H, Moriguchi A, Matsumoto K, Nakamura T, Kaneda Y, Ogihara T (2001) Contribution of Bcl-2 but not Bcl-xL and Bax, to anti-apoptotic actions of hepatocyte growth factor in hypoxic conditioned human endothelial cells. Hypertension 37:1341-1348
35. Nakamura Y, Morishita R, Nakamura S, Aoki M, Moriguchi A, Matsumoto K, Nakamura T, Higaki J, Ogihara T (1996) A vascular modulator, hepatocyte growth factor, is associated with systolic pressure. Hypertension 28:409-413
36. Nakamura Y, Morishita R, Higaki J, Kida I, Aoki M, Moriguchi A, Yamada K, Hayashi S, Yo Y, Nakano N, Matsumoto K, Nakamura T, Ogihara T (1996) Hepatocyte growth factor (HGF) is a novel member of endothelium-specific growth factors: additive stimulatory effect of HGF with basic fibroblast growth factor, but not vascular endothelial growth factor. J Hypertens 14:1067-1072
37. Morishita R, Higaki J, Miyazaki M, Ogihara T (1992) Possible role of the vascular renin-angiotensin system in hypertension and vascular hypertrophy. Hypertension 19:II62-II67
38. Okamura T, Miyazaki M, Inagami T, Toda N (1986) Vascular renin angiotensin system in two-kidney, one clip hypertensive rats. Hypertension 8:560-565
39. Nakagami H, Morishita R, Yamamoto K, Taniyama Y, Aoki M, Matsumoto K, Nakamura T, Kaneda Y, Horiuchi M, Ogihara T (2001) Mitogenic and anti-apoptotic actions of HGF through ERK, STAT3 and Akt in endothelial cells. Hypertension 37:581-586
40. Taniyama Y, Morishita R, Nakagami H, Moriguchi A, Sakonjo H, Kim S, Matsumoto K, Nakamura T, Higaki J, Ogihara T (2000) Potential contribution of a novel anti-fibrotic factor, hepatocyte growth factor, to prevention of myocardial fibrosis by angiotensin II blockade in cardiomyopathic hamster. Circulation 102:246-252
41. Van Belle E, Witzenbichler B, Chen D, Silver M, Chang L, Schwall R, Isner JM (1998) Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis. Circulation 97:381-390
42. Laitinen M, Zachary I, Breier G, Pakkanen T, Hakkinen T, Luoma J, Abedi H, Risau W, Soma M, Laakso M, Martin JF, Yla-Herttuala S (1997) VEGF gene transfer reduces intimal thickening via increased production of nitric oxide in carotid arteries. Hum Gene Ther 8:1737-1744
43. van der Zee R, Murohara T, Luo Z, Zollmann F, Passeri J, Lekutat C, Isner JM (1997) Vascular endothelial growth factor/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium. Circulation 95:1030-1037
44. Matsumoto K, Nakamura T (1996) Emerging multipotent aspect of hepatocyte growth factor. J Biochem 119:591-600
45. Rosen EM, Nigam SK, Goldberg ID (1994) Scatter factor and the c-met receptor: a paradigm for mesenchymal/epithelial interaction. J Cell Biol 127:1783-1787
46. Hamanoue M, Takao S, Shimazu H, Noji S, Matsumoto K, Nakamura T (1992) Rapid marked induction of hepatocyte growth factor during liver regeneration after ischemic or crush injury. Hepatology 16:1485-1492
47. Nagaike M, Hirao S, Tajima H, Noji S, Taniguchi S, Matsumoto K, Nakamura T (1991) Renotropic functions of hepatocyte growth factor in renal regeneration after unilateral nephrectomy. J Biol Chem 266:22781-22784
48. Nakamura S, Moriguchi A, Morishita R, Aoki M, Yo Y, Hayashi S, Nakano N, Katsuya T, Nakata S, Takami S, Matsumoto K, Nakamura T, Higaki J, Ogihara T (1998) A novel vascular modulator, hepatocyte growth factor (HGF), as a potential index of the severity of hypertension. Biochem Biophys Res Commun 242:238-243